• Leahy, making sure that the government does not have to disclose any information under the Freedom of Information Act relating to drug inspections from a foreign government agency;

• Sen. Rob PortmanRob PortmanOvernight Finance: Senators spar over Wall Street at SEC pick's hearing | New CBO score for ObamaCare bill | Agency signs off on Trump DC hotel lease GOP senators offer bill to require spending cuts with debt-limit hikes Vulnerable Senate Dem: Border tax concerning for agriculture MORE (R-Ohio), directing the attorney general to establish uniform standards for the exchange of controlled substance and prescription information for the purpose of preventing diversion, fraud and abuse of controlled substances and other prescription drugs; and,

• Sen. Tom CoburnTom CoburnDon't be fooled: Carper and Norton don't fight for DC Coburn: Trump's tweets aren't presidential The road ahead for America’s highways MORE (R-Okla.), to require an independent assessment of the FDA's review of drug applications.

ADVERTISEMENT
Also by unanimous consent, the Senate approved an amendment from Portman to place synthetic drugs on Schedule I of the Controlled Substances Act.

Harkin also announced that another amendment from Coburn would be withdrawn — a proposal to require the Health and Human Services secretary to ensure that performance awards are connected to employee evaluations.

Senate Majority Leader Harry ReidHarry ReidThis obscure Senate rule could let VP Mike Pence fully repeal ObamaCare once and for all Sharron Angle to challenge GOP rep in Nevada Fox's Watters asks Trump whom he would fire: Baldwin, Schumer or Zucker MORE (D-Nev.) said Thursday morning that he hoped some of the remaining 11 amendments to the FDA bill could be handled quickly. With the four unanimous consent votes, seven roll-call votes remain before final passage. These votes are scheduled for 2 p.m., but Reid said he hoped they might start earlier.